Stay updated with breaking news from Daniel Vitt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Issuer: Immunic, Inc. / Key word(s): Study Immunic Announces Start of Patient Cohorts in Its Phase 1 Clinical Trial of IMU-856 in Celiac Disease 05.05.2022 / 12:30 The issuer is
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Issuer: Immunic, Inc. / Key word(s): Conference Immunic, Inc. to Participate in Upcoming Investor and Industry Conferences 25.04.2022...
DGAP-News: Immunic, Inc. / Key word(s): Personnel Immunic, Inc. Announces Promotion of Glenn Whaley, CPA to Chief Financial Officer 16.03.2022 / 11:30 The issuer is solely responsible
/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused...